WebCo-founder and CEO at Tavros Therapeutics Durham, North Carolina, United States. 737 followers 500+ connections. Join to view profile Tavros Therapeutics. Duke University. Report this profile ... WebTavros Therapeutics 753 followers on LinkedIn. Leading the new frontier of targeted cancer therapies exploiting tumors’ genetic vulnerabilities. Tavros Therapeutics is a precision oncology platform company leading the new frontier of targeted therapies exploiting tumors’ genetic vulnerabilities. Tavros is also leveraging its proprietary platform …

Tavros Therapeutics plans larger facility after $7.5M raise to …

WebMay 28, 2024 · DURHAM — Tavros Therapeutics is collaborating with clinical-stage biopharmaceutical company Zentalis Pharmaceuticals to discover “a new frontier” in oncology therapy.. Under the arrangement ... WebTavros Therapeutics, Inc. is a North Carolina Foreign Business Corporation filed on July 14, 2024. The company's filing status is listed as Current-Active and its File Number is 2010680. The Registered Agent on file for this company is Mcdonnell, Eoin R. and is located at 701 West Main Street, Suite 200, Durham, NC 27701. tau-5

Durham biotech startup founded by Duke grad raises ... - WRAL …

WebMar 17, 2024 · Tavros Therapeutics General Information. Description. Developer of oncological drugs designed to treat cancer. The company's drug can make a significant … WebPosted 5:29:53 PM. Who is Tavros? Tavros Therapeutics is a precision oncology platform company leading the new ... Tavros Therapeutics Durham, NC. Research Associate. WebMar 29, 2024 · Tavros Therapeutics - Employs a high-throughput functional genomics discovery platform to uncover unique weaknesses in cancer cells that are exposed by drug treatment. The goal of Tavros’ platform is to identify a clear clinical path for novel drug development with the knowledge of predictive biomarkers and possible drug … tau55f